Diagnostics and Management of Tuberculosis and COVID-19 Co-Infection
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 223
Special Issue Editor
2. Center of Pulmonology and Allergology of Vilnius University Hospital Santaros Klinikos, Santariškių g. 2, LT-08661 Vilnius, Lithuania
Interests: COVID-19; lungs; tuberculosis
Special Issue Information
Dear Colleagues,
Tuberculosis is as old as humanity itself. This disease remains a serious worldwide health problem. A successful fight against tuberculosis highly depends on early diagnosis and proper continuous treatment of the disease. The significance of recognition of the early clinical symptoms of tuberculosis cannot be overstated. These symptoms are usually mild. They are often overlooked or misinterpreted during the COVID-19 pandemic. Persons with active pulmonary tuberculosis spreads the tuberculosis causative agent and disseminated infection.
Surprisingly, recent statistics show the decline in new tuberculosis cases and tuberculosis treatment rates that is disproportionate to the long-term trends in these rates. The COVID-19 pandemic disrupted the early diagnosis and management of many diseases. In many countries, care for people with tuberculosis is not working as well as it did before the pandemic. This suggests the fairly strong assumption that there will be an increase in tuberculosis cases shortly.
The dissemination of good clinical practice at this time is therefore particularly welcome. This Special Issue “Diagnostics and Management of Tuberculosis and COVID-19 Co-Infection” is dedicated to presenting and discussing the tuberculosis problems related to the COVID-19 pandemic. We invite you to submit your research (reviews, original papers, special case series, or exceptional clinical cases) intended for the links between tuberculosis and COVID-19. We invite you to share your and your country's experience in diagnosing, treating, and managing tuberculosis in a COVID-19 pandemic.
Prof. Dr. Edvardas Danila
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- lungs
- tuberculosis
